Why Navidea Biopharmaceuticals Shares Are Nosediving
Portfolio Pulse from Henry Khederian
Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares have dropped by 18.5% to $0.08 after the company announced that NYSE American has started delisting proceedings. The company plans to appeal the decision and if delisted, Navidea intends to quote its common stock in the over-the-counter market.
July 31, 2023 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Navidea Biopharmaceuticals shares have dropped significantly due to the announcement of delisting proceedings by NYSE American.
The announcement of delisting proceedings by NYSE American has led to a significant drop in Navidea Biopharmaceuticals' share price. This is a direct impact on the company's stock as it creates uncertainty among investors.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100